Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors.

Foster, Corey C; Couey, Marcus A; Kochanny, Sara E; Khattri, Arun; Acharya, Rajesh K; Tan, Yi-Hung Carol; Brisson, Ryan J; Leidner, Rom S; Seiwert, Tanguy Y

Foster, Corey C; Couey, Marcus A; Kochanny, Sara E; Khattri, Arun; Acharya, Rajesh K; Tan, Yi-Hung Carol; Brisson, Ryan J; Leidner, Rom S; Seiwert, Tanguy Y.

Afiliación

Foster CC; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
Couey MA; Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, Oregon.
Kochanny SE; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago Medicine, Chicago, Illinois.
Khattri A; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago Medicine, Chicago, Illinois.
Acharya RK; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago Medicine, Chicago, Illinois.
Tan YC; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago Medicine, Chicago, Illinois.
Brisson RJ; Department of Medicine, Henry Ford Hospital, Detroit, Michigan.
Leidner RS; Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, Oregon.
Seiwert TY; Departments of Oncology and Otolaryngology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.

Cancer ; 127(24): 4565-4573, 2021 12 15.

Article en En | MEDLINE | ID: mdl-34547103

Asunto(s)

Neoplasias de Cabeza y Cuello; Inhibidores de Puntos de Control Inmunológico; Neoplasias de Cabeza y Cuello/tratamiento farmacológico; Humanos; Inhibidores de Puntos de Control Inmunológico/efectos adversos; Recurrencia Local de Neoplasia; Supervivencia sin Progresión; Estudios Retrospectivos

Palabras clave

immune checkpoint inhibitor; immunotherapy; metastasis; squamous cell carcinoma of head and neck; toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias de Cabeza y Cuello Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google